Type 1 and type 2 diabetes are characterized by progressive β-cell failure. Apoptosis is probably the main form of β-cell death in both forms of the disease. It has been suggested …
V Poitout, RP Robertson - Endocrine reviews, 2008 - academic.oup.com
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary …
S Dinić, J Arambašić Jovanović, A Uskoković… - Frontiers in …, 2022 - frontiersin.org
The biggest drawback of a current diabetes therapy is the treatment of the consequences not the cause of the disease. Regardless of the diabetes type, preservation and recovery of …
V Poitout, J Amyot, M Semache, B Zarrouki… - … et Biophysica Acta (BBA …, 2010 - Elsevier
The concept of glucolipotoxicity refers to the combined, deleterious effects of elevated glucose, and fatty acid levels on pancreatic beta-cell function and survival. Significant …
IF Sevrioukova - Antioxidants & redox signaling, 2011 - liebertpub.com
Apoptosis-inducing factor (AIF) is a flavin adenine dinucleotide-containing, NADH- dependent oxidoreductase residing in the mitochondrial intermembrane space whose …
W El-Assaad, J Buteau, ML Peyot, C Nolan… - …, 2003 - academic.oup.com
We have proposed the “glucolipotoxicity” hypothesis in which elevated free fatty acids (FFAs) together with hyperglycemia are synergistic in causing islet β-cell damage because …
E Karaskov, C Scott, L Zhang, T Teodoro… - …, 2006 - academic.oup.com
Chronic free fatty acid (FFA) exposure induces pancreatic β-cell death, which may contribute to the development of type 2 diabetes. The mechanisms involved in FFA-induced cell death …
I Kharroubi, L Ladrière, AK Cardozo, Z Dogusan… - …, 2004 - academic.oup.com
Apoptosis is probably the main form of β-cell death in both type 1 diabetes mellitus (T1DM) and T2DM. In T1DM, cytokines contribute to β-cell destruction through nuclear factor-κB (NF …
N Ruderman, M Prentki - Nature reviews Drug discovery, 2004 - nature.com
Patients with the metabolic syndrome are characterized by insulin resistance, obesity and a predisposition to hypertension, dyslipidaemia, pancreatic β-cell dysfunction, type 2 diabetes …